<SEC-DOCUMENT>0001129928-24-000024-index.html : 20240412 <SEC-HEADER>0001129928-24-000024.hdr.sgml : 20240412 <ACCEPTANCE-DATETIME>20240412110338 ACCESSION NUMBER: 0001129928-24-000024 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20240412 FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOLYTICS BIOTECH INC CENTRAL INDEX KEY: 0001129928 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38512 FILM NUMBER: 24840407 BUSINESS ADDRESS: STREET 1: 804, 322 - 11 AVENUE SW CITY: CALGARY STATE: A0 ZIP: T2R 0C5 BUSINESS PHONE: 4036707380 MAIL ADDRESS: STREET 1: 804, 322 - 11 AVENUE SW CITY: CALGARY STATE: A0 ZIP: T2R 0C5 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>a2024informationcircularfo.htm <DESCRIPTION>6-K <TEXT> Document 1 - file: a2024informationcircularfo.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>onc-2024circularxfinal.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: onc-2024circularxfinal.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>oncolytics-proxy2024fina.htm <DESCRIPTION>EX-99.2 <TEXT> Document 3 - file: oncolytics-proxy2024fina.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>image_3.jpg <TEXT> Document 4 - file: image_3.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_5.jpg <TEXT> Document 5 - file: image_5.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_7.jpg <TEXT> Document 6 - file: image_7.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>oncolytics-proxy2024fina001.jpg <TEXT> Document 7 - file: oncolytics-proxy2024fina001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>oncolytics-proxy2024fina002.jpg <TEXT> Document 8 - file: oncolytics-proxy2024fina002.jpg
</DOCUMENT> </SEC-DOCUMENT>